Most Read News

Business Wire India Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and bioMérieux, a world leader in in vitro diagnostics, announced today that they have formed a joint venture to create the next generation of antimicrobials along with actionable diagnostics to fight Antimicrobial Resistance (AMR).   The resulting company, Aurobac Therapeutics […]

The Times of India reported that prescription sunblock sales surged by more than 55% in May compared to 2020, based on the most recent statistics gathered by research firm IMS.

Mr Tarun Bajaj, Revenue Secretary, Ministry of Finance, Government of India made three key points, while speaking as the Chief Guest at CII Interactive Session with Ministry of Finance on GST – Five Year Journey of Tax Transformation and the Way Forward in Delhi. The GST reform is undergoing an evolution. The Government is looking forward to having lower rates on fewer products, with indirect […]

Rategain Travel Technologies has allotted 8040 equity shares under ESOP on 04 July 2022. Consequent to the aforesaid allotment, the paid-up equity share capital of the Company has increased from Rs 108,189,602/- (108,189,602 equity shares of Rs 1/- each) to Rs 108,197,642 divided into (108,197,642 equity shares of Rs 1/- each). Powered by Capital Market – Live News

The solution makes use of AWS analytics, artificial intelligence, and machine learning services to uncover new insights at the sectoral, regional, and corporate levels, allowing users to build a portfolio of high-performing ESG companies.

Aurobindo Pharma announced that its wholly owned subsidiary company, Eugia Pharma Specialities, has received a final approval from the US Food & Drug Administration (USFDA) to manufacture and market Triamcinolone Acetonide Injectable Suspension 200 mg/5 mL & 400 mg/10 mL. Triamcinolone Acetonide Injectable Suspension USP, 200 mg/5 mL (40 mg/mL) Multiple-dose vials and 400 mg/10 mL (40 mg/mL) Multiple-dose vials, to be bioequivalent and therapeutically […]

Dabur India rose 1.88% to Rs 540.15 after the FMCG major said that its India business is expected to report high single digit revenue growth as compared to a very high base of 35.4% revenue growth in Q1 FY22.

TVS Electronics Ltd, Kridhan Infra Ltd, Cinevista Ltd and Jayaswal Neco Industries Ltd are among the other gainers in the BSEs B group today, 06 July 2022.

The company was honored among a global field of top Microsoft partners.

To deliver a differentiated digital experience for its customers